| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Charles N Serhan | Q87981947 |
| Derek W Gilroy | Q60571091 | ||
| Christopher D Buckley | Q87865766 | ||
| P2860 | cites work | High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation | Q21245689 |
| Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1 | Q24297600 | ||
| The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza | Q24324009 | ||
| 15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation | Q24645794 | ||
| Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals | Q24673096 | ||
| Anti-inflammatory therapy in chronic disease: challenges and opportunities | Q26860162 | ||
| Cyclooxygenase inhibition in sepsis: is there life after death? | Q27024316 | ||
| Resolution phase lipid mediators of inflammation: agonists of resolution | Q27687489 | ||
| Alternative activation of macrophages | Q27860939 | ||
| Myeloid-derived suppressor cells as regulators of the immune system | Q28131637 | ||
| Impact of CFTR DeltaF508 mutation on prostaglandin E2 production and type IIA phospholipase A2 expression by pulmonary epithelial cells | Q28181056 | ||
| Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX | Q28189315 | ||
| Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression | Q28199385 | ||
| Opposing and hierarchical roles of leukotrienes in local innate immune versus vascular responses in a model of sepsis | Q45232026 | ||
| Resolvin E1 metabolome in local inactivation during inflammation-resolution | Q46739796 | ||
| Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. | Q52512619 | ||
| Short communication: differences between macrophages and dendritic cells in the cyclic AMP-dependent regulation of lipopolysaccharide-induced cytokine and chemokine synthesis. | Q53587457 | ||
| Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host | Q57054792 | ||
| Synthetic Prostacyclin Analogs Differentially Regulate Macrophage Function via Distinct Analog-Receptor Binding Specificities | Q58209909 | ||
| Regulation of macrophage phagocytosis of apoptotic cells by cAMP | Q60129335 | ||
| Inducible cyclooxygenase-derived 15-deoxyΔ12-14PGJ2 brings about acute inflammatory resolution in rat pleurisy by inducing neutrophil and macrophage apoptosis | Q61053472 | ||
| Transforming growth factor-beta stimulation of lung fibroblast prostaglandin E2 production | Q69652259 | ||
| Influence of prostaglandin I2 on fibronectin-mediated phagocytosis in vivo and in vitro | Q70078047 | ||
| Plasma levels of 15-keto-13,14-dihydro-prostaglandin E2 in patients with bronchogenic carcinoma | Q70938415 | ||
| Regulation of IL-4 and IL-5 secretion by histamine and PGE2 | Q71111653 | ||
| Prostanoid biosynthesis in patients with cystic fibrosis | Q73026356 | ||
| Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators | Q73382034 | ||
| Enhanced expression of inducible cyclooxygenase with age in murine macrophages | Q73648223 | ||
| Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis | Q77671554 | ||
| Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2 | Q77841261 | ||
| A critical role of leukotriene B4 in neutrophil migration to infectious focus in cecal ligaton and puncture sepsis | Q78857445 | ||
| Apoptotic cells, through transforming growth factor-beta, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages | Q79287661 | ||
| Apoptotic cells induce immunosuppression through dendritic cells: critical roles of IFN-gamma and nitric oxide | Q81803393 | ||
| Resolvin D1 protects mice from LPS-induced acute lung injury | Q83894289 | ||
| Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation | Q84847121 | ||
| BLT1-dependent alveolar recruitment of CD4(+)CD25(+) Foxp3(+) regulatory T cells is important for resolution of acute lung injury | Q84942480 | ||
| Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice | Q85224255 | ||
| Infection regulates pro-resolving mediators that lower antibiotic requirements | Q42095762 | ||
| Resolvin D1, an endogenous lipid mediator for inactivation of inflammation-related signaling pathways in microglial cells, prevents lipopolysaccharide-induced inflammatory responses. | Q42693504 | ||
| Maresin 1, a proresolving lipid mediator derived from omega-3 polyunsaturated fatty acids, exerts protective actions in murine models of colitis. | Q42709394 | ||
| Protein kinase A inhibits leukotriene synthesis by phosphorylation of 5-lipoxygenase on serine 523. | Q42826850 | ||
| Lipid mediator class switching during acute inflammation: signals in resolution. | Q43655799 | ||
| Possible new role for NF-kappaB in the resolution of inflammation. | Q43811439 | ||
| Cyclooxygenase-2-issued prostaglandin e(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions | Q43891702 | ||
| Modulation of inflammation in vivo through induction of the heat shock response, effects on NF-kappaB activation | Q43942228 | ||
| Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). | Q44097824 | ||
| Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor | Q44127968 | ||
| Lipoxin a4 increases survival by decreasing systemic inflammation and bacterial load in sepsis | Q44478098 | ||
| Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation | Q28210028 | ||
| Posttreatment with aspirin-triggered lipoxin A4 analog attenuates lipopolysaccharide-induced acute lung injury in mice: the role of heme oxygenase-1 | Q28218062 | ||
| Candida albicans modulates host defense by biosynthesizing the pro-resolving mediator resolvin E1 | Q28471781 | ||
| Macrophage plasticity and polarization: in vivo veritas | Q29547620 | ||
| The chemokine system in diverse forms of macrophage activation and polarization | Q29547719 | ||
| Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators | Q29615694 | ||
| Leukotrienes and lipoxins: structures, biosynthesis, and biological effects | Q29617543 | ||
| Resolvin E1 and protectin D1 activate inflammation-resolution programmes | Q29618679 | ||
| The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation | Q29620219 | ||
| Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution. | Q30486807 | ||
| Resolvin E2 formation and impact in inflammation resolution | Q30513627 | ||
| Microfluidic chambers for monitoring leukocyte trafficking and humanized nano-proresolving medicines interactions | Q30530417 | ||
| Resolvin D2 restores neutrophil directionality and improves survival after burns | Q30539988 | ||
| Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo | Q30561804 | ||
| Modification and activation of Ras proteins by electrophilic prostanoids with different structure are site-selective | Q33284125 | ||
| Anesthetics impact the resolution of inflammation | Q33326614 | ||
| Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis | Q33513370 | ||
| Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? | Q33683210 | ||
| Contributions of neutrophils to resolution of mucosal inflammation | Q33719500 | ||
| Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production | Q33831917 | ||
| Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain | Q34130101 | ||
| Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation | Q34157528 | ||
| The cyclopentenone 15-deoxy-delta 12,14-prostaglandin J2 binds to and activates H-Ras | Q34189442 | ||
| Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators | Q34282093 | ||
| Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators | Q34294883 | ||
| The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury | Q34400164 | ||
| 15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit | Q34516493 | ||
| Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity | Q34597051 | ||
| A quantum theory for the irreplaceable role of docosahexaenoic acid in neural cell signalling throughout evolution | Q34645953 | ||
| Effects of low-dose aspirin on acute inflammatory responses in humans. | Q34992083 | ||
| Natural versus adaptive regulatory T cells | Q35092554 | ||
| Resolvins and protectins in inflammation resolution. | Q35332873 | ||
| Baking reduces prostaglandin, resolvin, and hydroxy-fatty acid content of farm-raised Atlantic salmon (Salmo salar) | Q35567528 | ||
| Total synthesis and bioactivity of 18(R)-hydroxyeicosapentaenoic acid | Q35660645 | ||
| 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. | Q35698498 | ||
| Inflammatory resolution: new opportunities for drug discovery | Q35770168 | ||
| Identification and structure determination of novel anti-inflammatory mediator resolvin E3, 17,18-dihydroxyeicosapentaenoic acid | Q35879986 | ||
| Natural regulatory T cells in infectious disease | Q36078051 | ||
| Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing | Q36376065 | ||
| Exogenous pathogen and plant 15-lipoxygenase initiate endogenous lipoxin A4 biosynthesis | Q36399221 | ||
| Resolvin D1 attenuates inflammation in lipopolysaccharide-induced acute lung injury through a process involving the PPARγ/NF-κB pathway | Q36535613 | ||
| Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? | Q36620178 | ||
| Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents | Q36642003 | ||
| Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways | Q36647303 | ||
| Prostaglandin E2 suppresses lipopolysaccharide-stimulated IFN-beta production | Q36677435 | ||
| Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2. | Q36693412 | ||
| FOXP3 modifies the phenotypic and functional properties of regulatory T cells | Q36767504 | ||
| Diversity of lipid mediators in human adipose tissue depots. | Q36923555 | ||
| The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype | Q36945083 | ||
| Stromal mesenteric lymph node cells are essential for the generation of gut-homing T cells in vivo | Q36946528 | ||
| Regulatory T cell populations in sepsis and trauma. | Q36959555 | ||
| Novel biphasic role for lymphocytes revealed during resolving inflammation | Q37014326 | ||
| Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signaling | Q37061898 | ||
| Resolvin D2 prevents secondary thrombosis and necrosis in a mouse burn wound model | Q37102819 | ||
| 15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury | Q37318201 | ||
| CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury | Q37363024 | ||
| Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues | Q37378205 | ||
| The role of T regulatory cells in human sepsis | Q37432707 | ||
| Human inflammatory and resolving lipid mediator responses to resistance exercise and ibuprofen treatment. | Q37440655 | ||
| Plasticity of leukocytic exudates in resolving acute inflammation is regulated by MicroRNA and proresolving mediators | Q37465090 | ||
| Lipoxins: regulators of resolution | Q37708528 | ||
| Transcriptomic analyses of murine resolution-phase macrophages | Q37716039 | ||
| Macrophage polarization and bacterial infections | Q37839626 | ||
| n-3 fatty acids in cardiovascular disease | Q37893165 | ||
| Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids. | Q37992090 | ||
| Manifold beneficial effects of acetyl salicylic acid and nonsteroidal anti-inflammatory drugs on sepsis. | Q38005318 | ||
| Aromatic lipoxin A4 and lipoxin B4 analogues display potent biological activities | Q40062355 | ||
| Upregulation of VEGF by 15-deoxy-Delta12,14-prostaglandin J2 via heme oxygenase-1 and ERK1/2 signaling in MCF-7 cells | Q40154397 | ||
| Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP. | Q40501682 | ||
| Response to self antigen imprints regulatory memory in tissues | Q40573313 | ||
| The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group | Q40653300 | ||
| Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP. | Q41782419 | ||
| Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis | Q41952624 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 315-327 | |
| P577 | publication date | 2014-03-01 | |
| P1433 | published in | Immunity | Q6005457 |
| P1476 | title | Proresolving lipid mediators and mechanisms in the resolution of acute inflammation | |
| P478 | volume | 40 |
| Q57823849 | A Broad-Spectrum ROS-Eliminating Material for Prevention of Inflammation and Drug-Induced Organ Toxicity |
| Q89592488 | A Modular, Enantioselective Synthesis of Resolvins D3, E1, and Hybrids |
| Q64997779 | A maresin 1/RORα/12-lipoxygenase autoregulatory circuit prevents inflammation and progression of nonalcoholic steatohepatitis. |
| Q41455682 | AMP-activated protein kinase suppresses arachidonate 15-lipoxygenase expression in interleukin 4-polarized human macrophages |
| Q47132202 | Absence of the Non-Signalling Chemerin Receptor CCRL2 Exacerbates Acute Inflammatory Responses In Vivo. |
| Q37545061 | Accelerated resolution of inflammation underlies sex differences in inflammatory responses in humans. |
| Q57147098 | Activated Human Lung Fibroblasts Produce Extracellular Vesicles with Anti-Fibrotic Prostaglandins |
| Q47102876 | Actors and Factors in the Resolution of Intestinal Inflammation: Lipid Mediators As a New Approach to Therapy in Inflammatory Bowel Diseases |
| Q33848554 | Acyloxyacyl hydrolase promotes the resolution of lipopolysaccharide-induced acute lung injury |
| Q26783097 | Addressing the Complications of Ebola and Other Viral Hemorrhagic Fever Infections: Using Insights from Bacterial and Fungal Sepsis |
| Q30372594 | Adipose tissue NAPE-PLD controls fat mass development by altering the browning process and gut microbiota. |
| Q27014988 | Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs |
| Q64072416 | Advances in Sport and Performance Nutrition |
| Q55057811 | Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines. |
| Q98224792 | Alox12/15 Deficiency Exacerbates, While Lipoxin A4 Ameliorates Hepatic Inflammation in Murine Alcoholic Hepatitis |
| Q41364404 | Analysis of endogenous lipids during intestinal wound healing. |
| Q47979606 | Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases. |
| Q24318444 | Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair. |
| Q38846007 | Annexin A1: shifting the balance towards resolution and repair |
| Q59327139 | Annexins in Influenza Virus Replication and Pathogenesis |
| Q55353902 | Anti-Inflammatory Benefits of Antibiotics: Tylvalosin Induces Apoptosis of Porcine Neutrophils and Macrophages, Promotes Efferocytosis, and Inhibits Pro-Inflammatory CXCL-8, IL1α, and LTB4 Production, While Inducing the Release of Pro-Resolving Lipo |
| Q38644797 | Anti-inflammatory and antioxidative effects of Camellia oleifera Abel components |
| Q99604991 | Antimicrobial Effects of Thymosin Beta-4 and Ciprofloxacin Adjunctive Therapy in Pseudomonas aeruginosa Induced Keratitis |
| Q36342136 | Aspirin enhances protective effect of fish oil against thrombosis and injury-induced vascular remodelling |
| Q44909658 | Association of a variant in the gene encoding for ERV1/ChemR23 with reduced inflammation in visceral adipose tissue from morbidly obese individuals |
| Q35276192 | Atf3 negatively regulates Ptgs2/Cox2 expression during acute inflammation |
| Q93012793 | Atherothrombosis and the NLRP3 inflammasome - endogenous mechanisms of inhibition |
| Q40214715 | B Cell Activity Is Impaired in Human and Mouse Obesity and Is Responsive to an Essential Fatty Acid upon Murine Influenza Infection |
| Q36861048 | Bigelovii A Protects against Lipopolysaccharide-Induced Acute Lung Injury by Blocking NF-κB and CCAAT/Enhancer-Binding Protein δ Pathways |
| Q49679435 | Bioactive Lipids and Chronic Inflammation: Managing the Fire Within. |
| Q38946768 | Biomimetic synthesis of hemiketal eicosanoids for biological testing. |
| Q101038645 | Blood pro-resolving mediators are linked with synovial pathology and are predictive of DMARD responsiveness in rheumatoid arthritis |
| Q93140729 | CaMKII Activity in the Inflammatory Response of Cardiac Diseases |
| Q46265550 | Carbon Monoxide in Lung Cell Physiology and Disease |
| Q34519343 | Cell-cell interactions and bronchoconstrictor eicosanoid reduction with inhaled carbon monoxide and resolvin D1. |
| Q42145331 | Cellular dynamics of resolving inflammation |
| Q99240040 | Comprehensive Evaluation of Lipopolysaccharide-Induced Changes in Rats Based on Metabolomics |
| Q36454140 | Consumption of Buglossoides arvensis seed oil is safe and increases tissue long-chain n-3 fatty acid content more than flax seed oil - results of a phase I randomised clinical trial |
| Q37216844 | Cortisol-treated zebrafish embryos develop into pro-inflammatory adults with aberrant immune gene regulation. |
| Q36180681 | Critical role of phospholipase A2 group IID in age-related susceptibility to severe acute respiratory syndrome-CoV infection. |
| Q38357052 | Curcumin and omega-3 fatty acids enhance NK cell-induced apoptosis of pancreatic cancer cells but curcumin inhibits interferon-γ production: benefits of omega-3 with curcumin against cancer. |
| Q34455625 | Cutting edge: maresin-1 engages regulatory T cells to limit type 2 innate lymphoid cell activation and promote resolution of lung inflammation |
| Q35117086 | Cytokine and lipid mediator networks in tuberculosis |
| Q91636313 | Cytokines and beyond: Regulation of innate immune responses during helminth infection |
| Q90412529 | DELineating resolution of inflammation |
| Q92156614 | Decreased Blood Level of MFSD2a as a Potential Biomarker of Alzheimer's Disease |
| Q90928695 | Dietary DHA amplifies LXA4 circuits in tissues and lymph node PMN and is protective in immune-driven dry eye disease |
| Q58761427 | Dietary Supplementation With ω6 LC-PUFA-Rich Algae Modulates Zebrafish Immune Function and Improves Resistance to Streptococcal Infection |
| Q64245612 | Dietary arachidonate in milk replacer triggers dual benefits of PGE signaling in LPS-challenged piglet alveolar macrophages |
| Q48157381 | Dietary modulation of oxylipins in cardiovascular disease and aging |
| Q35727514 | Dietary ω3 fatty acid exerts anti-allergic effect through the conversion to 17,18-epoxyeicosatetraenoic acid in the gut. |
| Q48226915 | Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System. |
| Q38941290 | Differential Expression of the Eicosanoid Pathway in Patients With Localized or Mucosal Cutaneous Leishmaniasis |
| Q48375838 | Docosahexaenoic acid, but not eicosapentaenoic acid, improves septic shock-induced arterial dysfunction in rats |
| Q58790211 | Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial) |
| Q62661525 | Dynamic changes to lipid mediators support transitions among macrophage subtypes during muscle regeneration |
| Q90193544 | ER-Mitochondria Communication in Cells of the Innate Immune System |
| Q64063300 | Early Prophylactic Hypothermia for Patients With Severe Traumatic Injury: Premature to Close the Case |
| Q91973569 | Editorial: HIV and Cancer Immunotherapy: Similar Challenges and Converging Approaches |
| Q35137287 | Effect of pulsed electromagnetic field treatment on programmed resolution of inflammation pathway markers in human cells in culture |
| Q35122536 | Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients |
| Q90675220 | Effects of Pranoprofen on Aqueous Humor Monocyte Chemoattractant Protein-1 Level and Pain Relief During Second-Eye Cataract Surgery |
| Q47209132 | Eicosanoid Diversity of Stony Corals. |
| Q93184796 | Eicosanoids metabolized through LOX distinguish asthma-COPD overlap from COPD by metabolomics study |
| Q52719088 | Endogenous PGI2 signaling through IP inhibits neutrophilic lung inflammation in LPS-induced acute lung injury mice model. |
| Q57922233 | Energy Demands of Early Life Drive a Disease Tolerant Phenotype and Dictate Outcome in Neonatal Bacterial Sepsis |
| Q38701709 | Epigenetic regulation of gene expression and M2 macrophage polarization as new potential omega-3 polyunsaturated fatty acid targets in colon inflammation and cancer |
| Q60300574 | Epigenetics of chronic inflammatory diseases |
| Q26752941 | Evasion of Neutrophil Killing by Staphylococcus aureus |
| Q26745566 | Evolving Insights on Metabolism, Autophagy, and Epigenetics in Liver Myofibroblasts |
| Q35610800 | Exaggerated Acute Lung Injury and Impaired Antibacterial Defenses During Staphylococcus aureus Infection in Rats with the Metabolic Syndrome |
| Q41033728 | Extracellular signal-regulated kinase 5 promotes acute cellular and systemic inflammation |
| Q36655802 | Factors Associated with Multiple Biomarkers of Systemic Inflammation. |
| Q35621848 | Fatty acid remodeling by LPCAT3 enriches arachidonate in phospholipid membranes and regulates triglyceride transport. |
| Q90483887 | Formyl peptide receptor 2 regulates monocyte recruitment to promote intestinal mucosal wound repair |
| Q39434474 | From Inflammation to Fibrosis-Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities |
| Q40171791 | Frontline Science: Aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology |
| Q91921361 | Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes |
| Q90259466 | Glycolipid iGb3 feedback amplifies innate immune responses via CD1d reverse signaling |
| Q36727399 | Group X Secreted Phospholipase A2 Releases ω3 Polyunsaturated Fatty Acids, Suppresses Colitis, and Promotes Sperm Fertility |
| Q93133646 | Gut microbiota confers host resistance to obesity by metabolizing dietary polyunsaturated fatty acids |
| Q90389244 | HMGB1-C1q complexes regulate macrophage function by switching between leukotriene and specialized proresolving mediator biosynthesis |
| Q99709259 | Human Mesenchymal Stromal Cell Secretome Promotes the Immunoregulatory Phenotype and Phagocytosis Activity in Human Macrophages |
| Q42784201 | Human lung fibroblasts produce proresolving peroxisome proliferator-activated receptor-γ ligands in a cyclooxygenase-2-dependent manner |
| Q48189143 | Identification of Novel Chondroprotective Mediators in Resolving Inflammatory Exudates |
| Q39067604 | Immune resolution mechanisms in inflammatory arthritis |
| Q49888772 | Immune responsive resolvin D1 programs myocardial infarction-induced cardiorenal syndrome in heart failure. |
| Q89139365 | Immunoregulatory role of 15-lipoxygenase in the pathogenesis of bacterial keratitis |
| Q35781384 | Impact of a Standard Rodent Chow Diet on Tissue n-6 Fatty Acids, Δ9-Desaturation Index, and Plasmalogen Mass in Rats Fed for One Year. |
| Q47133736 | Impaired Resolution of Inflammation in Alzheimer's Disease: A Review |
| Q89581848 | Impaired lipid metabolism by age-dependent DNA methylation alterations accelerates aging |
| Q35849963 | In Vivo Availability of Pro-Resolving Lipid Mediators in Oxazolone Induced Dermal Inflammation in the Mouse |
| Q38594922 | In the eye of the neutrophil swarm-navigation signals that bring neutrophils together in inflamed and infected tissues |
| Q64100827 | In vitro and in vivo assessment of the proresolutive and antiresorptive actions of resolvin D1: relevance to arthritis |
| Q64228664 | Inflammation Resolution and the Induction of Granulocyte Apoptosis by Cyclin-Dependent Kinase Inhibitor Drugs |
| Q38902578 | Inflammation and the Intestinal Barrier: Leukocyte-Epithelial Cell Interactions, Cell Junction Remodeling, and Mucosal Repair |
| Q42334005 | Inflammatory Pathways in Knee Osteoarthritis: Potential Targets for Treatment |
| Q34549969 | Inflammatory mechanisms in tendinopathy - towards translation |
| Q35560054 | Inhibition of Corneal Inflammation by the Resolvin E1. |
| Q90240416 | Inhibition of Δ24-dehydrocholesterol reductase activates pro-resolving lipid mediator biosynthesis and inflammation resolution |
| Q30242022 | Innate immune responses in the ageing lung |
| Q46237015 | Interferon Potentiates Toll-Like Receptor-Induced Prostaglandin D2 Production through Positive Feedback Regulation between Signal Transducer and Activators of Transcription 1 and Reactive Oxygen Species |
| Q47120837 | Interplay Between n-3 and n-6 Long-Chain Polyunsaturated Fatty Acids and the Endocannabinoid System in Brain Protection and Repair |
| Q26749606 | Key mechanisms governing resolution of lung inflammation |
| Q40696194 | Lipidomic analysis of patients with microbial invasion of the amniotic cavity reveals up-regulation of leukotriene B4. |
| Q92368340 | Lipoprotein-associated phospholipase A2: The story continues |
| Q34614336 | Lysophospholipid acyltransferases and eicosanoid biosynthesis in zebrafish myeloid cells |
| Q37041858 | Macrophage Proresolving Mediators-the When and Where |
| Q54225686 | Macrophage-Derived Extracellular Vesicles Induce Long-Lasting Immunity Against Hepatitis C Virus Which Is Blunted by Polyunsaturated Fatty Acids. |
| Q34847925 | Macrophages are required for host survival in experimental urogenital schistosomiasis |
| Q91937728 | Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD |
| Q91583510 | Maresin 1 Mitigates Sepsis-Associated Acute Kidney Injury in Mice via Inhibition of the NF-κB/STAT3/MAPK Pathways |
| Q45983433 | Maresin 1 Promotes Inflammatory Resolution, Neuroprotection, and Functional Neurological Recovery After Spinal Cord Injury. |
| Q52576158 | Maresins: Specialized Proresolving Lipid Mediators and Their Potential Role in Inflammatory-Related Diseases. |
| Q42247775 | Mass spectrometry profiling of oxylipins, endocannabinoids, and N-acylethanolamines in human lung lavage fluids reveals responsiveness of prostaglandin E2 and associated lipid metabolites to biodiesel exhaust exposure |
| Q38603141 | MerTK Cleavage on Resident Cardiac Macrophages Compromises Repair after Myocardial Ischemia Reperfusion Injury |
| Q37183630 | MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation |
| Q91734896 | MerTK signaling in macrophages promotes the synthesis of inflammation resolution mediators by suppressing CaMKII activity |
| Q64086168 | Mesenchymal Stem Cells Reverse Diabetic Nephropathy Disease via Lipoxin A4 by Targeting Transforming Growth Factor β (TGF-β)/smad Pathway and Pro-Inflammatory Cytokines |
| Q50062519 | Metabolic regulation of macrophage phenotype and function. |
| Q97520988 | Modulation of the Inflammatory Response and Bone Healing |
| Q57073314 | Multivalent nanosystems: targeting monocytes/macrophages |
| Q94599572 | N-AS-triggered SPMs are direct regulators of microglia in a model of Alzheimer's disease |
| Q38405308 | NLRP3 Inflammasome Deficiency Protects Against Microbial Sepsis via Increased Lipoxin B4 Synthesis |
| Q52584637 | Neuronal SphK1 acetylates COX2 and contributes to pathogenesis in a model of Alzheimer's Disease. |
| Q37722754 | Neutrophil migration in infection and wound repair: going forward in reverse. |
| Q38936502 | Neutrophil swarming: an essential process of the neutrophil tissue response |
| Q92861017 | Neutrophils as emerging therapeutic targets |
| Q64058093 | Neutrophils promote the development of reparative macrophages mediated by ROS to orchestrate liver repair |
| Q48104478 | Neutrophils: Beneficial and Harmful Cells in Septic Arthritis. |
| Q59328942 | Neutrophils: Innate Effectors of TB Resistance? |
| Q37238202 | New paradigms in sepsis: from prevention to protection of failing microcirculation |
| Q28274634 | Novel Endogenous Proresolving Molecules:Essential Fatty Acid-Derived and Gaseous Mediators in the Resolution of Inflammation |
| Q34464346 | Novel proresolving and tissue-regenerative resolvin and protectin sulfido-conjugated pathways |
| Q90859346 | Omega-3 fatty acids are a potential therapy for patients with sickle cell disease |
| Q59130594 | Oral administration of the selective GPR120/FFA4 agonist compound A is not effective in alleviating tissue inflammation in mouse models of prototypical autoimmune diseases |
| Q92405052 | Osteoimmunology of Oral and Maxillofacial Diseases: Translational Applications Based on Biological Mechanisms |
| Q37272119 | PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation. |
| Q26771755 | PPARγ and the Innate Immune System Mediate the Resolution of Inflammation |
| Q52369219 | Paradigm shift - Metabolic transformation of docosahexaenoic and eicosapentaenoic acids to bioactives exemplify the promise of fatty acid drug discovery. |
| Q47243662 | Participation of delta annexin A3 in the ribosomal protein S19 C-terminus-dependent inhibitory mechanism of the neutrophil C5a receptor through delta lactoferrin |
| Q38596702 | Pathophysiology of Myocardial Infarction |
| Q37089046 | Phagocyte respiratory burst activates macrophage erythropoietin signalling to promote acute inflammation resolution. |
| Q78177016 | Pharmacological plasticity-How do you hit a moving target? |
| Q41235810 | Plasma metabolomics profiles in rats with acute traumatic brain injury |
| Q57183595 | Polyunsaturated fatty acid elongation and desaturation in activated human T cells: ELOVL5 is the key elongase |
| Q36777563 | Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis |
| Q90735171 | Pro-resolving lipid mediators in the resolution of neointimal hyperplasia pathogenesis in atherosclerotic diseases |
| Q42367800 | Proresolving Lipid Mediators Restore Balance to the Vulnerable Plaque |
| Q91973416 | Proresolving Lipid Mediators: Endogenous Modulators of Oxidative Stress |
| Q27334082 | Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis |
| Q36727452 | Prostaglandins from Cytosolic Phospholipase A2α/Cyclooxygenase-1 Pathway and Mitogen-activated Protein Kinases Regulate Gene Expression in Candida albicans-infected Macrophages |
| Q30300194 | Recent insights into the cellular biology of atherosclerosis |
| Q92669248 | Recombinant human thrombomodulin attenuated sepsis severity in a non-surgical preterm mouse model |
| Q92105279 | Regulation and Functions of 15-Lipoxygenases in Human Macrophages |
| Q61807003 | Regulation of Type 2 Immunity in Myocardial Infarction |
| Q38899898 | Regulation of inflammation by lipid mediators in oral diseases |
| Q57069785 | Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution |
| Q39150054 | Resident macrophages in the healthy and inflamed intestinal muscularis externa. |
| Q37603197 | Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology |
| Q37619977 | Resolution of Cancer-Promoting Inflammation: A New Approach for Anticancer Therapy |
| Q90268996 | Resolution of Crohn's disease |
| Q26747410 | Resolution of Inflammation: What Controls Its Onset? |
| Q90886252 | Resolution of inflammation and mood disorders |
| Q49228468 | Resolution of inflammation and sepsis survival are improved by dietary Ω-3 fatty acids. |
| Q39367753 | Resolution of inflammation in inflammatory bowel disease |
| Q38791244 | Resolution of inflammation: a new therapeutic frontier |
| Q58592833 | Resolution of sickle cell disease associated inflammation and tissue damage with 17R-Resolvin D1 |
| Q36656030 | Resolvin D1 Dampens Pulmonary Inflammation and Promotes Clearance of Nontypeable Haemophilus influenzae |
| Q54974225 | Resolvin D1 promotes corneal epithelial wound healing and restoration of mechanical sensation in diabetic mice. |
| Q55250059 | Resolvin D2 Restrains Th1 Immunity and Prevents Alveolar Bone Loss in Murine Periodontitis. |
| Q40956866 | Resolvin D2 decreases TLR4 expression to mediate resolution in human monocytes |
| Q92105357 | Resolvin D5 Inhibits Neuropathic and Inflammatory Pain in Male But Not Female Mice: Distinct Actions of D-Series Resolvins in Chemotherapy-Induced Peripheral Neuropathy |
| Q90240149 | Resolving Inflammation: Synthesis, Configurational Assignment, and Biological Evaluations of RvD1n-3 DPA |
| Q39046533 | Resolving inflammation by using nutrition therapy: roles for specialized proresolving mediators |
| Q36174560 | Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages |
| Q33621441 | Role of GATA transcription factor ELT-2 and p38 MAPK PMK-1 in recovery from acute P. aeruginosa infection in C. elegans |
| Q90626539 | Role of dietary fatty acids in microglial polarization in Alzheimer's disease |
| Q57177488 | Role of oxylipins in cardiovascular diseases |
| Q92684821 | RvE1 treatment prevents memory loss and neuroinflammation in the Ts65Dn mouse model of Down syndrome |
| Q28547300 | Simvastatin and Benznidazole-Mediated Prevention of Trypanosoma cruzi-Induced Endothelial Activation: Role of 15-epi-lipoxin A4 in the Action of Simvastatin |
| Q91641349 | Skin Acute Wound Healing: A Comprehensive Review |
| Q60947291 | Specialized Pro-resolving Lipid Mediators: Modulation of Diabetes-Associated Cardio-, Reno-, and Retino-Vascular Complications |
| Q40140858 | Specialized Pro-resolving Mediators (SPM) Rescue Infant Mice from Lethal Citrobacter rodentium Infection and Promote Immunity against Re-infection |
| Q90341456 | Specialized Pro-resolving Mediators Directs Cardiac Healing and Repair with Activation of Inflammation and Resolution Program in Heart Failure |
| Q88540273 | Specialized Proresolving Mediators in Innate and Adaptive Immune Responses in Airway Diseases |
| Q28271331 | Specialized pro-resolving mediators: endogenous regulators of infection and inflammation |
| Q26767382 | Sphingolipids and Epoxidized Lipid Metabolites in the Control of Gut Immunosurveillance and Allergy |
| Q91819996 | Sphingolipids in neuroinflammation: a potential target for diagnosis and therapy |
| Q91783144 | Stabilization and improved activity of arachidonate 11S-lipoxygenase from proteobacterium Myxococcus xanthus |
| Q42626453 | Strict Regiospecificity of Human Epithelial 15-Lipoxygenase-2 Delineates Its Transcellular Synthesis Potential |
| Q39197238 | Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors |
| Q49609716 | Structural insights into Resolvin D4 actions and further metabolites via a new total organic synthesis and validation. |
| Q33442820 | Survival, bacterial clearance and thrombocytopenia are improved in polymicrobial sepsis by targeting nuclear transport shuttles. |
| Q89414736 | Surviving sepsis campaign: research priorities for sepsis and septic shock |
| Q38241177 | Switching off key signaling survival molecules to switch on the resolution of inflammation. |
| Q61797993 | Sympathetic nervous system controls resolution of inflammation via regulation of repulsive guidance molecule A |
| Q39002910 | Systemic Bioavailability and Dose Proportionality of Omega-3 Administered in Free Fatty Acid Form Compared With Ethyl Ester Form: Results of a Phase 1 Study in Healthy Volunteers |
| Q93012264 | TNFα promotes mucosal wound repair through enhanced platelet activating factor receptor signaling in the epithelium |
| Q37544674 | Targeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis. |
| Q39649085 | Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice |
| Q47571628 | Targeting Hypoxia Signaling for Perioperative Organ Injury |
| Q39062582 | Targeting P-selectin glycoprotein ligand-1/P-selectin interactions as a novel therapy for metabolic syndrome |
| Q38255645 | Targeting eicosanoid pathways in the development of novel anti-influenza drugs |
| Q38553529 | Targeting inflammation in metabolic syndrome. |
| Q55419461 | The Central Role of the Inflammatory Response in Understanding the Heterogeneity of Sepsis-3. |
| Q88442422 | The G-Protein-Coupled Receptor ALX/Fpr2 Regulates Adaptive Immune Responses in Mouse Submandibular Glands |
| Q92406465 | The Prostaglandin D2 Receptor CRTH2 Promotes IL-33-Induced ILC2 Accumulation in the Lung |
| Q61814324 | The Protectin Family of Specialized Pro-resolving Mediators: Potent Immunoresolvents Enabling Innovative Approaches to Target Obesity and Diabetes |
| Q92982650 | The Role of Fish Oil in Inflammatory Eye Diseases |
| Q37677655 | The Specific Roles of Vitamins in the Regulation of Immunosurveillance and Maintenance of Immunologic Homeostasis in the Gut. |
| Q35163583 | The cyclopentenone prostaglandin 15d-PGJ2 inhibits the NLRP1 and NLRP3 inflammasomes |
| Q58740602 | The gut microbiota promotes hepatic fatty acid desaturation and elongation in mice |
| Q38991057 | The immune system's role in sepsis progression, resolution, and long-term outcome |
| Q41682707 | The low molecular weight fraction of human serum albumin upregulates COX2, prostaglandin E2, and prostaglandin D2 under inflammatory conditions in osteoarthritic knee synovial fibroblasts |
| Q39365490 | The novel lipid mediator PD1n-3 DPA: An overview of the structural elucidation, synthesis, biosynthesis and bioactions |
| Q94663995 | Therapeutic potential of lipids obtained from γ-irradiated PBMCs in dendritic cell-mediated skin inflammation |
| Q37231179 | Topical delivery of aqueous micellar resolvin E1 analog (RX-10045) |
| Q39088075 | Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms |
| Q47985657 | Tumor Necrosis Factor α-Dependent Neutrophil Priming Prevents Intestinal Ischemia/Reperfusion-Induced Bacterial Translocation |
| Q39084591 | Type I Interferons in Bacterial Infections: A Balancing Act. |
| Q91643187 | UV radiation recruits CD4+GATA3+ and CD8+GATA3+ T cells while altering the lipid microenvironment following inflammatory resolution in human skin in vivo |
| Q88640276 | Unified nexus of macrophages and maresins in cardiac reparative mechanisms |
| Q36407218 | Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis |
| Q26801818 | Wound repair: role of immune-epithelial interactions |
| Q35906366 | Xuefu Zhuyu decoction, a traditional Chinese medicine, provides neuroprotection in a rat model of traumatic brain injury via an anti-inflammatory pathway |
Search more.